DTA Standardizes Definition Of Digital Therapeutics
Executive Summary
The Digital Therapeutics Alliance (DTA) released a standardized definition and guidance for digital therapeutics during its annual meeting in Washington, DC. The move comes as part of a push toward standardization for the fast-changing field.
You may also be interested in...
The Frontier Of Digital Therapeutics Regulations
Panelists at DTA’s 2023 Inaugural Summit explored the landscape of DTX regulations across the world.
The Afterlife Of Pear Therapeutics: Korean DTx Maker Discusses Vision For Salvaged Migraine Assets
WELT USA was among four companies that competed at auction for Pear assets following the digital therapeutics trailblazer’s Chapter 11 bankruptcy filing in April. WELT also bid on Pear’s reSET assets for treating substance use disorder, but was pleased that they went to Pear’s former CEO Corey McCann – “a good signal to the industry,” says WELT USA head Danny Kim.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.